ELCC 2016: Phase 2 trial of chemotherapy plus gefitinib as first-line treatment for lung adenocarcinoma

At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 13–16 April 2016, Giorgio Scagliotti, MD, PhD, from the University of Turin, Turin, Italy, discusses a phase 2 tria... Author: VJOncology Added: 05/10/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts